325 related articles for article (PubMed ID: 33176316)
1. Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism.
Sato N; Matsuo R; Kiyuna F; Nakamura K; Hata J; Wakisaka Y; Ago T; Kamouchi M; Kitazono T;
Cerebrovasc Dis; 2020; 49(6):601-608. PubMed ID: 33176316
[TBL] [Abstract][Full Text] [Related]
2. Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation.
Witte KK; Tsivgoulis G; Reynolds MR; Tsintzos SI; Eggington S; Ismyrloglou E; Lyon J; Huynh M; Egea M; de Brouwer B; Ziegler PD; Franco N; Joglekar R; Rosemas SC; Liu S; Thijs V
BMC Cardiovasc Disord; 2021 Mar; 21(1):160. PubMed ID: 33789592
[TBL] [Abstract][Full Text] [Related]
3. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
[TBL] [Abstract][Full Text] [Related]
4. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial.
Ntaios G; Pearce LA; Veltkamp R; Sharma M; Kasner SE; Korompoki E; Milionis H; Mundl H; Berkowitz SD; Connolly SJ; Hart RG;
Stroke; 2020 Jun; 51(6):1797-1804. PubMed ID: 32295509
[TBL] [Abstract][Full Text] [Related]
5. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
Shoamanesh A; Hart RG; Connolly SJ; Kasner SE; Smith EE; Martí-Fàbregas J; Liu YY; Uchiyama S; Mikulik R; Veltkamp R; O'Donnell MJ; Ntaios G; Muir KW; Field TS; Santo GC; Olavarria V; Mundl H; Lutsep H; Berkowitz SD; Sharma M
JAMA Neurol; 2021 Jan; 78(1):11-20. PubMed ID: 33074284
[TBL] [Abstract][Full Text] [Related]
6. Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
Merkler AE; Pearce LA; Kasner SE; Shoamanesh A; Birnbaum LA; Kamel H; Sheth KN; Sharma R
JAMA Neurol; 2021 Dec; 78(12):1454-1460. PubMed ID: 34694346
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
Veltkamp R; Pearce LA; Korompoki E; Sharma M; Kasner SE; Toni D; Ameriso SF; Mundl H; Tatlisumak T; Hankey GJ; Lindgren A; Berkowitz SD; Arauz A; Ozturk S; Muir KW; Chamorro Á; Perera K; Shuaib A; Rudilosso S; Shoamanesh A; Connolly SJ; Hart RG
JAMA Neurol; 2020 Oct; 77(10):1233-1240. PubMed ID: 32628266
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Adding Antiplatelets to Oral Anticoagulants in Patients with Acute Ischemic Stroke with Atrial Fibrillation and Concomitant Large Artery Steno-Occlusion.
Kim JT; Lee JS; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Park MS; Choi KH; Cho KH; Lee J; Gorelick PB; Bae HJ
Transl Stroke Res; 2020 Dec; 11(6):1322-1331. PubMed ID: 32472251
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
[TBL] [Abstract][Full Text] [Related]
10. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study.
Perera KS; de Sa Boasquevisque D; Rao-Melacini P; Taylor A; Cheng A; Hankey GJ; Lee S; Fabregas JM; Ameriso SF; Field TS; Arauz A; Coutts SB; Arnold M; Mikulik R; Toni D; Mandzia J; Veltkamp RC; Meseguer E; Haeusler KG; Hart RG;
JAMA Neurol; 2022 May; 79(5):450-458. PubMed ID: 35285869
[TBL] [Abstract][Full Text] [Related]
12. High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source.
Scheitz JF; Pare G; Pearce LA; Mundl H; Peacock WF; Czlonkowska A; Sharma M; Nolte CH; Shoamanesh A; Berkowitz SD; Krahn T; Endres M;
Stroke; 2020 Aug; 51(8):2386-2394. PubMed ID: 32640945
[TBL] [Abstract][Full Text] [Related]
13. Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source during 3 Years of Prolonged Monitoring with an Implantable Loop Recorder.
Kitsiou A; Rogalewski A; Kalyani M; Deelawar S; Tribunyan S; Greeve I; Minnerup J; Israel C; Schäbitz WR
Thromb Haemost; 2021 Jun; 121(6):826-833. PubMed ID: 33401327
[TBL] [Abstract][Full Text] [Related]
14. Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source.
Ntaios G; Vemmos K; Lip GY; Koroboki E; Manios E; Vemmou A; Rodríguez-Campello A; Cuadrado-Godia E; Giralt-Steinhauer E; Arnao V; Caso V; Paciaroni M; Diez-Tejedor E; Fuentes B; Pérez Lucas J; Arauz A; Ameriso SF; Hawkes MA; Pertierra L; Gómez-Schneider M; Bandini F; Chavarria Cano B; Iglesias Mohedano AM; García Pastor A; Gil-Núñez A; Putaala J; Tatlisumak T; Barboza MA; Athanasakis G; Makaritsis K; Papavasileiou V
Stroke; 2016 Sep; 47(9):2278-85. PubMed ID: 27507859
[TBL] [Abstract][Full Text] [Related]
15. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
16. Increased Incident Ischemic Stroke Risk in Advanced Kidney Disease: A Large-Scale Real-World Data Study.
Maeda T; Nishi T; Funakoshi S; Tada K; Tsuji M; Satoh A; Kawazoe M; Yoshimura C; Arima H
Am J Nephrol; 2020; 51(8):659-668. PubMed ID: 32726780
[TBL] [Abstract][Full Text] [Related]
17. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
Ntaios G
J Am Coll Cardiol; 2020 Jan; 75(3):333-340. PubMed ID: 31976872
[TBL] [Abstract][Full Text] [Related]
18. Non vitamin K oral anticoagulants versus antiplatelets in embolic stroke of undetermined source: most updated evidence.
Chatterjee S; Dubey S; Lahiri D; Ray BK
Minerva Cardioangiol; 2019 Aug; 67(4):340-347. PubMed ID: 31220915
[TBL] [Abstract][Full Text] [Related]
19. Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke.
Kiyuna F; Sato N; Matsuo R; Kamouchi M; Hata J; Wakisaka Y; Kuroda J; Ago T; Kitazono T;
JAMA Netw Open; 2018 Sep; 1(5):e182953. PubMed ID: 30646186
[TBL] [Abstract][Full Text] [Related]
20. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.
Ameriso SF; Amarenco P; Pearce LA; Perera KS; Ntaios G; Lang W; Bereczki D; Uchiyama S; Kasner SE; Yoon BW; Lavados P; Firstenfeld A; Mikulik R; Povedano GP; Ferrari J; Mundl H; Berkowitz SD; Connolly SJ; Hart RG
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104936. PubMed ID: 32689594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
